Zilda-D 100/10
Composition
Vildagliptin 100 mg SR + Dapagliflozin 10 mg Tablets
Description
Vildagliptin, a member of the islet enhancer class, is a potent and selective dipeptidyl-peptidase-4 (DPP-4) inhibitor that improves glycaemic control. SGLT2 inhibitors, also called gliflozins, are a class of medications that alter essential physiology of the nephron; unlike SGLT1 inhibitors that modulate sodium/glucose channels in the intestinal mucosa. Zilda-D provides cardio-renal protection, minimal hypoglycaemia, weight reduction and achieve A1C goal of 7%.
Zilda M 500/850/1000
Composition
Vildagliptin 50 mg + Metformin 500/850/1000 mg Tablets
Description
It is used in addition to diet and exercise to improve control of blood glucose (sugar) levels in adults with type 2 diabetes.
Zilda 50
Composition
Vildagliptin 50 mg Tablets
Description
Vildagliptin, a member of the islet enhancer class, is a potent and selective dipeptidyl-peptidase-4 (DPP-4) inhibitor that improves glycaemic control. Vildagliptin inhibition of DPP-4 results in increased fasting and postprandial endogenous levels of the incretin hormones GLP-1 (glucagon-like peptide 1) and GIP (glucose-dependent insulinotropic polypeptide). The administration of vildagliptin results in rapid and complete inhibition of DPP-4 activity. In patients with type 2 diabetes, administration of vildagliptin led to inhibition of DPP-4 enzyme activity for a 24-hour period.